These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7642656)

  • 21. Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation.
    Serrano SMT; Wang D; Shannon JD; Pinto AFM; Polanowska-Grabowska RK; Fox JW
    FEBS J; 2007 Jul; 274(14):3611-3621. PubMed ID: 17578514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ASP514 within the A1 domain of bovine von Willebrand factor is required for interaction with platelet glycoprotein Ib.
    Sinha D; Bakhshi M; Kunapuli S; Vora R; Gabriel JL; Kirby EP; Budzynski AZ
    Biochem Biophys Res Commun; 1994 Sep; 203(2):881-8. PubMed ID: 8093071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of von Willebrand factor to collagen type III: role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains.
    van der Plas RM; Gomes L; Marquart JA; Vink T; Meijers JC; de Groot PG; Sixma JJ; Huizinga EG
    Thromb Haemost; 2000 Dec; 84(6):1005-11. PubMed ID: 11154106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor.
    Riddell AF; Gomez K; Millar CM; Mellars G; Gill S; Brown SA; Sutherland M; Laffan MA; McKinnon TA
    Blood; 2009 Oct; 114(16):3489-96. PubMed ID: 19687512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of peptides, selected by phage display technology, that inhibit von Willebrand factor binding to collagen.
    Depraetere H; Viaene A; Deroo S; Vauterin S; Deckmyn H
    Blood; 1998 Dec; 92(11):4207-11. PubMed ID: 9834225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. von Willebrand factor without the A2 domain is resistant to proteolysis.
    Lankhof H; Damas C; Schiphorst ME; Ijsseldijk MJ; Bracke M; Furlan M; Tsai HM; de Groot PG; Sixma JJ; Vink T
    Thromb Haemost; 1997 May; 77(5):1008-13. PubMed ID: 9184419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression in Escherichia coli of a recombinant fragment (Ile 914-Leu 1364) of human von Willebrand factor containing a collagen binding domain.
    Jorieux S; Piétu G; Gaucher C; Mischler F; Meulien P; Meyer D; Mazurier C
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):375-84. PubMed ID: 2133214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII.
    Fischer BE; Kramer G; Mitterer A; Grillberger L; Reiter M; Mundt W; Dorner F; Eibl J
    Thromb Res; 1996 Oct; 84(1):55-66. PubMed ID: 8885147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A3 domain is essential for interaction of von Willebrand factor with collagen type III.
    Lankhof H; van Hoeij M; Schiphorst ME; Bracke M; Wu YP; Ijsseldijk MJ; Vink T; de Groot PG; Sixma JJ
    Thromb Haemost; 1996 Jun; 75(6):950-8. PubMed ID: 8822592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
    Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP
    Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propolypeptide and mature portions of von Willebrand factor of bovine origin recognize different sites on type-I collagen obtained from bovine tendon.
    Usui T; Fujisawa T; Takagi J; Saito Y
    Eur J Biochem; 1992 Apr; 205(1):363-7. PubMed ID: 1555595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.
    Matsushita T; Sadler JE
    J Biol Chem; 1995 Jun; 270(22):13406-14. PubMed ID: 7539426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of von Willebrand factor to collagen and glycoprotein Ibalpha, but not to glycoprotein IIb/IIIa, contributes to ischemic stroke in mice--brief report.
    De Meyer SF; Schwarz T; Deckmyn H; Denis CV; Nieswandt B; Stoll G; Vanhoorelbeke K; Kleinschnitz C
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1949-51. PubMed ID: 20616311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interventional thermal injury of the arterial wall: unfolding of von Willebrand factor and its increased binding to collagen after 55 degrees C heating.
    Post MJ; de Graaf-Bos AN; Posthuma G; de Groot PG; Sixma JJ; Borst C
    Thromb Haemost; 1996 Mar; 75(3):515-9. PubMed ID: 8701418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen.
    Denis C; Baruch D; Kielty CM; Ajzenberg N; Christophe O; Meyer D
    Arterioscler Thromb; 1993 Mar; 13(3):398-406. PubMed ID: 8443144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disulfide bonds required to assemble functional von Willebrand factor multimers.
    Dong Z; Thoma RS; Crimmins DL; McCourt DW; Tuley EA; Sadler JE
    J Biol Chem; 1994 Mar; 269(9):6753-8. PubMed ID: 8120035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity.
    Daidone V; Saga G; Barbon G; Pontara E; Cattini MG; Morpurgo M; Zanotti G; Casonato A
    Br J Haematol; 2015 Aug; 170(4):564-73. PubMed ID: 25904363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative evaluation of a new fully automated assay for von Willebrand factor collagen binding activity to an established method.
    Stufano F; Baronciani L; Mane-Padros D; Cozzi G; Faraudo S; Peyvandi F
    Haemophilia; 2018 Jan; 24(1):156-161. PubMed ID: 29168270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen.
    Ribba AS; Loisel I; Lavergne JM; Juhan-Vague I; Obert B; Cherel G; Meyer D; Girma JP
    Thromb Haemost; 2001 Sep; 86(3):848-54. PubMed ID: 11583318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa.
    Marx I; Christophe OD; Lenting PJ; Rupin A; Vallez MO; Verbeuren TJ; Denis CV
    Blood; 2008 Aug; 112(3):603-9. PubMed ID: 18487513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.